CST3 and Alzheimer disease: It makes preliminary and exploratory connections between the molecular mechanisms underlying AD endotypes and clinical measures such as EASI, eosinophil count, and cystatin C levels—parameters that, pending further functional validation, could be readily incorporated into clinical practice.